These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10433373)

  • 41. Prevention by mannan and other sugars of in vitro damage of rat fetal small intestine induced by cereal prolamin peptides toxic for human celiac intestine.
    Auricchio S; De Ritis G; De Vincenzi M; Latte F; Maiuri L; Pino A; Raia V; Silano V
    Pediatr Res; 1987 Dec; 22(6):703-7. PubMed ID: 3431955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease.
    Hischenhuber C; Crevel R; Jarry B; Mäki M; Moneret-Vautrin DA; Romano A; Troncone R; Ward R
    Aliment Pharmacol Ther; 2006 Mar; 23(5):559-75. PubMed ID: 16480395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intestinal mucosa of celiacs in remission is unable to abolish toxicity of gliadin peptides on in vitro developing fetal rat intestine and cultured atrophic celiac mucosa.
    Cornell HJ; Auricchio RS; De Ritis G; De Vincenzi M; Maiuri L; Raia V; Silano V
    Pediatr Res; 1988 Aug; 24(2):233-7. PubMed ID: 3186334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An in vitro model of gluten-sensitive enteropathy. Effect of gliadin on intestinal epithelial cells of patients with gluten-sensitive enteropathy in organ culture.
    Falchuk ZM; Gebhard RL; Sessoms C; Strober W
    J Clin Invest; 1974 Feb; 53(2):487-500. PubMed ID: 11344562
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppressor-cell activity in coeliac disease induced by alpha-gliadin, a dietary antigen.
    O'Farrelly C; Whelan CA; Feighery CF; Weir DG
    Lancet; 1984 Dec; 2(8415):1305-7. PubMed ID: 6150324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early tissue transglutaminase-mediated response underlies K562(S)-cell gliadin-dependent agglutination.
    Silano M; Vincentini O; Luciani A; Felli C; Caserta S; Esposito S; Villella VR; Pettoello-Mantovani M; Guido S; Maiuri L
    Pediatr Res; 2012 May; 71(5):532-8. PubMed ID: 22314661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Innovative approach to low-level gluten determination in foods using a novel sandwich enzyme-linked immunosorbent assay protocol.
    Valdés I; García E; Llorente M; Méndez E
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):465-74. PubMed ID: 12702901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation and characterization of enzymatically hydrolyzed prolamins from wheat, rye, and barley as references for the immunochemical quantitation of partially hydrolyzed gluten.
    Gessendorfer B; Koehler P; Wieser H
    Anal Bioanal Chem; 2009 Nov; 395(6):1721-8. PubMed ID: 19763549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proteomic analysis in allergy and intolerance to wheat products.
    Mamone G; Picariello G; Addeo F; Ferranti P
    Expert Rev Proteomics; 2011 Feb; 8(1):95-115. PubMed ID: 21329430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Barley and rye prolamins induce an mRNA interferon-gamma response in coeliac mucosa.
    Bracken SC; Kilmartin C; Wieser H; Jackson J; Feighery C
    Aliment Pharmacol Ther; 2006 May; 23(9):1307-14. PubMed ID: 16629935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies on the aetiology of coeliac disease: no evidence for lectin-like components in wheat gluten.
    Rühlmann J; Sinha P; Hansen G; Tauber R; Köttgen E
    Biochim Biophys Acta; 1993 Jun; 1181(3):249-56. PubMed ID: 8318550
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunologic evidence of no harmful effect of oats in celiac disease.
    Picarelli A; Di Tola M; Sabbatella L; Gabrielli F; Di Cello T; Anania MC; Mastracchio A; Silano M; De Vincenzi M
    Am J Clin Nutr; 2001 Jul; 74(1):137-40. PubMed ID: 11451729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An in vitro animal model for the study of cereal components toxic in celiac disease.
    Auricchio S; Cardelli M; De Ritis G; De Vincenzi M; Latte F; Silano V
    Pediatr Res; 1984 Dec; 18(12):1372-8. PubMed ID: 6441144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Non-coeliac gluten sensitivity: hype, or new epidemic?].
    Nijeboer P; Mulder C; Bouma G
    Ned Tijdschr Geneeskd; 2013; 157(21):A6168. PubMed ID: 23693012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The "gluten-free" situation.
    Ward MR
    J Hum Nutr; 1980 Apr; 34(2):149-50. PubMed ID: 7373034
    [No Abstract]   [Full Text] [Related]  

  • 56. In vitro pathogenetic studies of coeliac disease. Effects of protein digests on coeliac intestinal biopsy specimens maintained in culture for 48 hours.
    Jos J; Lenoir G; Ritis G D; Rey J
    Scand J Gastroenterol; 1975; 10(2):121-8. PubMed ID: 1091964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A radioimmunoassay for wheat gliadin to assess the suitability of gluten free foods for patients with coeliac disease.
    Ciclitira PJ; Ellis HJ; Evans DJ; Lennox ES
    Clin Exp Immunol; 1985 Mar; 59(3):703-8. PubMed ID: 3987095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The toxicity of certain cereal proteins in coeliac disease.
    Cornell HJ; Townley RR
    Gut; 1974 Nov; 15(11):862-9. PubMed ID: 4455563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coeliac disease--a meeting point for genetics, immunology, and protein chemistry.
    Mowat AM
    Lancet; 2003 Apr; 361(9365):1290-2. PubMed ID: 12699968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intestinal T cell responses to cereal proteins in celiac disease.
    Kilmartin C; Wieser H; Abuzakouk M; Kelly J; Jackson J; Feighery C
    Dig Dis Sci; 2006 Jan; 51(1):202-9. PubMed ID: 16416236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.